Cargando…
Hybrid-control arm construction using historical trial data for an early-phase, randomized controlled trial in metastatic colorectal cancer
BACKGROUND: Treatment for metastatic colorectal cancer patients beyond the second line remains challenging, highlighting the need for early phase trials of combination therapies for patients who had disease progression during or following two prior lines of therapy. Leveraging hybrid control design...
Autores principales: | Li, Chen, Ferro, Ana, Mhatre, Shivani K., Lu, Danny, Lawrance, Marcus, Li, Xiao, Li, Shi, Allen, Simon, Desai, Jayesh, Fakih, Marwan, Cecchini, Michael, Pedersen, Katrina S., Kim, Tae You, Reyes-Rivera, Irmarie, Segal, Neil H., Lenain, Christelle |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9287310/ https://www.ncbi.nlm.nih.gov/pubmed/35856081 http://dx.doi.org/10.1038/s43856-022-00155-y |
Ejemplares similares
-
Building External Control Arms From Patient-Level Electronic Health Record Data to Replicate the Randomized IMblaze370 Control Arm in Metastatic Colorectal Cancer
por: Schröder, Carsten, et al.
Publicado: (2021) -
Augmenting control arms with real-world data for cancer trials: Hybrid control arm methods and considerations
por: Tan, W. Katherine, et al.
Publicado: (2022) -
Estimation of historical control rate for a single arm de-escalation study – Application to the POSITIVE trial
por: Sun, Zhuoxin, et al.
Publicado: (2020) -
Pertuzumab Plus Trastuzumab for Treatment-Refractory HER2-Amplified Metastatic Colorectal Cancer: Comparison of the MyPathway Trial With a Real-World External Control Arm
por: Narita, Yusuke, et al.
Publicado: (2022) -
Experimental Treatment with Favipiravir for Ebola Virus Disease (the JIKI Trial): A Historically Controlled, Single-Arm Proof-of-Concept Trial in Guinea
por: Sissoko, Daouda, et al.
Publicado: (2016)